Table 2.
Mean value comparison between anthropometric and metabolic parameters in non-Hodgkin’s lymphomas (NHL) patients with or without metabolic syndrome.
| DLBCL (N = 60) | |||
|---|---|---|---|
| MetSyn/yes (N = 36) | MetSyn/no (N = 24) | p-Value | |
| Anthropometry | |||
| Weight (Kg) | 76.3 ± 14.0 | 73.0 ± 13.0 | n.s |
| Height (cm) | 169.5 ± 2.5 | 166.5 ± 6.7 | n.s |
| BMI (kg/h2) | 27.5 ± 4.5 | 26.6 ± 4.2 | n.s |
| Waist circumference | |||
| Women | 98.0 ± 17.0 | 84.0 ± 11.0 | 0.001 |
| Men | 104.0 ± 9.0 | 93.3 ± 8.1 | 0.005 |
| Percentage body fat | |||
| Women | 39.5 ± 5.0 | 38.4 ± 2.6 | ns |
| Men | 32.1 ± 4.2 | 28.2 ± 5.0 | 0.04 |
| Percentage fat-free mass | |||
| Women | 60.6 ± 4.0 | 61.5 ± 2.5 | 0.45 |
| Men | 67.9 ± 4.1 | 71.7 ± 5.0 | 0.002 |
| TDEE | 2113 ± 309 | 2185 ± 275 | ns |
| Inflammatory markers | |||
| CRP (mg/dL) | 2.10 ± 2.02 | 1.90 ± 1.01 | n.s |
| β2-microglobulin (mg/L) | 1.08 ± 0.45 | 1.82 ± 0.45 | 0.001 |
| Metabolic parameters | |||
| Glycemia (mg/dL) | 101.5 ± 17.0 | 99.3 ± 7.2 | n.s |
| Total cholesterol (mg/dL) | 201.0 ± 30.8 | 199.0 ± 21.0 | n.s |
| HDL-cholesterol (mg/dL) | 52.4 ± 11.9 | 53.0 ± 11.0 | n.s |
| Triglycerides(mg/dL) | 133.2 ± 12 | 130.3 ± 6.0 | n.s |
| Albumin (%) | 55.5 ± 5.3 | 56.1 ± 4.7 | n.s |
| TFR | 250.5 ± 35.0 | 270.7 ± 31.0 | n.s |
| HCT | 41.7 ± 3.8 | 43.5 ± 2.5 | n.s |
MetSyn, Metabolic syndrome; DLBC, diffuse large B-cell lymphoma; BMI, Body Mass Index; TDEE, Total Daily Energy Expenditure; CRP, C-Reactive Protein); HDL- C, High Density lipoprotein- Cholesterol; TFR, Transferrin; HCT, Hematocrit.